D.E. Shaw & Co’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
D.E. Shaw & Co's EIKN Position: Q3 2026 in Review
D.E. Shaw & Co opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 39,240 shares worth $315K. The stake represents ﹤0.01% of the portfolio and ranks #4464 among its holdings.
98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.
- D.E. Shaw & Co held 39,240 shares of Eikon Therapeutics worth $315K as of Q3 2026.
- Eikon Therapeutics was a new D.E. Shaw & Co position in Q3 2026.
- Eikon Therapeutics made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q3 2026, its #4464 holding.
- 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.